Overall, our findings support a relationship between the HDL-C/ApoA-I index with an adverse cardiometabolic profile and subclinical atherosclerosis that could be used to evaluate cardiovascular disease in adults without CAD. This evidence concerns the gene APOA1 and atherosclerosis.